Aspira Women's Health Inc.

AWHLOTC· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$9.2M

▲ 0.4% YoY

Net Income

-$12.8M

▲ 2.4% YoY

EPS

$-0.37

▲ 60.2% YoY

Cash

$1.8M

▼ 0.8% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.